13 Responses

  1. Friday Six: But Not On Friday. - Six Until Me - diabetes blog

    [...] JDRF appoints Derek Rapp as new President & CEO – here’s more information on this change in leadership from the mothership itself, and a post about the changing leadership of ADA and JDRF on Diabetes Mine. [...]

  2. John
    John July 24, 2014 at 6:23 am | | Reply

    Great post.

  3. Puddin
    Puddin July 24, 2014 at 10:10 am | | Reply

    Thank you this was informative. I am certain some folks will disapprove of Mr. Rapp because he was employed by Monsanto. I am not one of them so I appreciate the response John Brady gave to that topic.

  4. Allison Nimlos
    Allison Nimlos July 24, 2014 at 10:29 am | | Reply

    I just don’t understand how you can say “Great job! You’ve met all of your objectives! You’re fired!” It just doesn’t make sense to fire leadership for meeting their goals. What’s the incentive to do a good job if that’s the mentality?

    1. Mike Ratrie
      Mike Ratrie July 24, 2014 at 1:05 pm | | Reply

      Corporate-speak strikes again! In the case of the JDRF, the statement was “… we achieved MOST of our goals …” Oh, to be a fly on the wall.

      To focus on the positive, the JDRF and the ADA have made great strides over the last several years. Clearly with nearly 30 million diabetics and the looming pandemic that has 1 in 3 being saddled with some form of “D”, even greater strides are needed. I can only hope the new leaders, staff, researchers, volunteers and the current “D” club are up to taking them on.

  5. pegleggreg
    pegleggreg July 24, 2014 at 10:35 am | | Reply

    “To insinuate that Derek is not qualified to lead JDRF because of his past employment with Monsanto is not only unjustified, it’s pure nonsense. I find it offensive”
    Why so defensive? a legitimate question?

  6. Vicki
    Vicki July 24, 2014 at 2:11 pm | | Reply

    I don’t see that the outgoing CEO of ADA has made a lot of progress. As many in the greater diabetes community believe and so do I that the ADA is the last to make needed changes or updates.

  7. Cindy Martin
    Cindy Martin July 25, 2014 at 4:33 am | | Reply

    You can’t blame the skeptics. As part of the leadership of Monsanto, Rapp has served as a direct arm of the company–a company that has used coercive tactics to control international markets, a company that has repeatedly bullied independent American farmers in US Patent courts, that has refused to take responsibility for environmental cleanup after chemical spills, and that has refused to investigate claims of adverse health effects caused by its products. Monsanto represents the worst of corporate America and it’s reputation here and abroad is quite negative. The mere association of Rapp with Monsanto will soil JDRF’s reputation, whether logical or fair. Rapp will have to work extra hard to distance himself from Monsanto and prove to JDRF’s constituents that he can run an organization that takes a humane approach to its operations.

    1. Puddin
      Puddin July 25, 2014 at 8:26 am | | Reply

      I do blame the skeptics…Mr Rapp is not Monsanto. He was employed by them. For all we know, he was the dissenter against the bulldog tactics that you describe.

      And I do not think the JDRF or the constituents should spend any energy- not one ounce of it – defending Rapp or distancing him from his career. It is divisive and political rife with hidden agendas.

      Let’s just let the man get to work.

  8. John
    John July 25, 2014 at 6:28 pm | | Reply

    Leadership comes and goes but the bedside results will remain the same. We will still be injecting insulin and pricking our fingers by time Mr. Rapp decides, or is asked, to leave the JDRF. The JDRF has had a nice, easy ride with little results as far as real bedside impact to diabetes and better glucose monitors and a pump truly doesn’t count. It has not lessened the burden of managing T1.

    Most of the not for profits have gotten away with a myriad of excuses on why their is no real bedside progress but they have all the academic progress to fill encyclopedia brittanica 10 times over. “Walk for a cure” is really walk to cure mice over and over and over.

    Now, donors are feeling cheated and misled and want ROI. It is unacceptable to continue with the status quo.

    Mr. Brady can defend the JDRF’s hiring decision but donors are entitled to ask the hard questions and if you don’t like it, take your bat and ball and go home.

    The JDRF is not doing nearly enough in cure based research and bedside results. Their spend is purposely spread thin and way too much is spent on technologies or disease maintenance.

  9. Larry Hausner Steps Down as ADA Head this Week | The Juvenile Diabetes Cure Alliance Blog

    [...] an interim CEO will be put into place while the ADA searches for their next organization leader. DiabetesMines had an interview with the CEO, discussing both his tenure and the future of the [...]

  10. Brian
    Brian July 28, 2014 at 1:58 pm | | Reply

    One Mr. Rapp could have look for another job if he was not happy with what Monsanto was doing. On another note. I do not think corporate type used to bottom line and shareholders makes a good CEO for a non-profit organization seeking a cure. Oh that is right, The JDRF is only interesting in getting the AP(which will cost people a lot of money), to market, Than they will claim they have cured diabetes. Which is not a cure.

  11. Diabetes News and Views - 8/1/14 | War On Diabetes

    [...] Big Changes in Leadership at the JDRF and ADA. “The tides are a changin’ at two of the top diabetes orgs, with both the JDRF and the American Diabetes Association getting new leaders this month for the first time in years.”  It does seem a bit strange that both organizations are getting new leaders at the same time, but there you have it. Coincidence? I just don’t know. But the article does mention something about donors wanting a bigger impact on the direction the organizations are going. Both have served the Diabetes Community very well and as regular readers know, the ADA is one of the sources I routinely cite. [...]

Leave a Reply